These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

198 related items for PubMed ID: 10160088

  • 21. A pharmacoeconomic analysis of IV H2-receptor antagonist use in 40 hospitals.
    Segal R, Oh T, Ben-Joseph R, Russell WL.
    Hosp Formul; 1994 May; 29(5):379-82, 388-91. PubMed ID: 10136601
    [Abstract] [Full Text] [Related]

  • 22. Use of non-antacid antiulcer agents in the treatment of heartburn and dyspepsia.
    Sena MM, Stoddard ML, Pashko S.
    Clin Ther; 1994 May; 16(1):103-9. PubMed ID: 8205596
    [Abstract] [Full Text] [Related]

  • 23. Cost-Effectiveness of Histamine2 Receptor Antagonists Versus Proton Pump Inhibitors for Stress Ulcer Prophylaxis in Critically Ill Patients.
    Hammond DA, Kathe N, Shah A, Martin BC.
    Pharmacotherapy; 2017 Jan; 37(1):43-53. PubMed ID: 27809338
    [Abstract] [Full Text] [Related]

  • 24. On-demand treatment of acute heartburn with the antacid hydrotalcite compared with famotidine and placebo: randomized double-blind cross-over study.
    Holtmeier W, Holtmann G, Caspary WF, Weingärtner U.
    J Clin Gastroenterol; 2007 Jul; 41(6):564-70. PubMed ID: 17577112
    [Abstract] [Full Text] [Related]

  • 25. Over-the-counter H2-receptor antagonists for heartburn.
    Med Lett Drugs Ther; 1995 Oct 27; 37(960):95-6. PubMed ID: 7565298
    [No Abstract] [Full Text] [Related]

  • 26. Over-the-counter histamine2-blocker therapy.
    Gonzalez ER, Grillo JA.
    Ann Pharmacother; 1994 Mar 27; 28(3):392-5. PubMed ID: 7910767
    [Abstract] [Full Text] [Related]

  • 27. A randomized, double-blind, placebo-controlled clinical study of the histamine H2-receptor antagonist famotidine in Japanese patients with nonerosive reflux disease.
    Hongo M, Kinoshita Y, Haruma K.
    J Gastroenterol; 2008 Mar 27; 43(6):448-56. PubMed ID: 18600389
    [Abstract] [Full Text] [Related]

  • 28. The economic impact of payer policies after the Rx-to-OTC switch of second-generation antihistamines.
    Sullivan PW, Nichol MB.
    Value Health; 2004 Mar 27; 7(4):402-12. PubMed ID: 15449632
    [Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30. Therapeutic effects of famotidine on chronic symptomatic gastritis: subgroup analysis from FUTURE study.
    Kinoshita Y, Chiba T, FUTURE study group.
    J Gastroenterol; 2012 Apr 27; 47(4):377-86. PubMed ID: 22183857
    [Abstract] [Full Text] [Related]

  • 31. Self-medication in Greece: the financial impact from expanding the OTC market.
    Naoum V, Nomikos N, Naoum P, Athanasakis K, Kyriopoulos J.
    Int J Pharm Pract; 2021 Dec 04; 29(6):541-547. PubMed ID: 34633452
    [Abstract] [Full Text] [Related]

  • 32. Decision analysis of histamine H2-receptor antagonist maintenance therapy versus Helicobacter pylori eradication therapy: a randomised controlled trial in patients with continuing pain after duodenal ulcer.
    Tavakoli M, Prach AT, Malek M, Hopwood D, Senior BW, Murray FE.
    Pharmacoeconomics; 1999 Oct 04; 16(4):355-65. PubMed ID: 10623364
    [Abstract] [Full Text] [Related]

  • 33. Transitioning the second-generation antihistamines to over-the-counter status: a cost-effectiveness analysis.
    Sullivan PW, Follin SL, Nichol MB.
    Med Care; 2003 Dec 04; 41(12):1382-95. PubMed ID: 14668671
    [Abstract] [Full Text] [Related]

  • 34. Potential public sector cost-savings from over-the-counter access to oral contraceptives.
    Foster DG, Biggs MA, Phillips KA, Grindlay K, Grossman D.
    Contraception; 2015 May 04; 91(5):373-9. PubMed ID: 25732570
    [Abstract] [Full Text] [Related]

  • 35.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 36. A prospective randomized trial of either famotidine or omeprazole for the prevention of bleeding after endoscopic mucosal resection and the healing of endoscopic mucosal resection-induced ulceration.
    Yamaguchi Y, Katsumi N, Tauchi M, Toki M, Nakamura K, Aoki K, Morita Y, Miura M, Morozumi K, Ishida H, Takahashi S.
    Aliment Pharmacol Ther; 2005 Jun 04; 21 Suppl 2():111-5. PubMed ID: 15943857
    [Abstract] [Full Text] [Related]

  • 37. Shifting physician prescribing to a preferred histamine-2-receptor antagonist. Effects of a multifactorial intervention in a mixed-model health maintenance organization.
    Brufsky JW, Ross-Degnan D, Calabrese D, Gao X, Soumerai SB.
    Med Care; 1998 Mar 04; 36(3):321-32. PubMed ID: 9520957
    [Abstract] [Full Text] [Related]

  • 38. Self-selection and use patterns of over-the-counter omeprazole for frequent heartburn.
    Fendrick AM, Shaw M, Schachtel B, Allgood L, Allgood G, Grender J, Peura D.
    Clin Gastroenterol Hepatol; 2004 Jan 04; 2(1):17-21. PubMed ID: 15017628
    [Abstract] [Full Text] [Related]

  • 39. How Do US Gastroenterologists Use Over-the-Counter and Prescription Medications in Patients With Gastroesophageal Reflux and Chronic Constipation?
    Menees SB, Guentner A, Chey SW, Saad R, Chey WD.
    Am J Gastroenterol; 2015 Nov 04; 110(11):1516-25. PubMed ID: 26054623
    [Abstract] [Full Text] [Related]

  • 40. Strategy for developing a safe and cost-effective H2-receptor antagonist program.
    Quercia RA, Chow MS, Jay GT, Quintiliani R.
    Hosp Formul; 1991 Nov 04; 26 Suppl D():20-4. PubMed ID: 10136561
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 10.